Confo Therapeutics: Time for change
Confo Therapeutics wants to metamorphose from a tech company to a drug discovery company, and it has hired Cedric Ververken to guide the transition.
He joins from Ablynx, where he held several positions, among them VP Business Development. Ververken, who holds a PhD in bioscience engineering from KU Leuven, takes over from Stephane van Rooijen, who is stepping down.
NOD-Proteindesign.Andreas Heddergott/TUM.jpg
Certest
Consilium